Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garraway

Showing results (431-440 of 549) with videos related to

Pageof 55
Sort By:
JAMA Oncology|July 17, 2015
Fusobacterium nucleatum and T Cells in Colorectal CarcinomaKosuke Mima, Yasutaka Sukawa, Reiko Nishihara, et al.
Nature Medicine|October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerA Vaishnavi, M Capelletti, A T Le, et al.
Genome Research|February 25, 2010
Integrative analysis of the melanoma transcriptomeMichael F Berger, Joshua Z Levin, Krishna Vijayendran, et al.
European Urology Oncology|June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed TherapyJesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Gut|August 28, 2015
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosisKosuke Mima, Reiko Nishihara, Zhi Rong Qian, et al.
Nature Medicine|May 10, 2019
The landscape of cancer cell line metabolismHaoxin Li, Shaoyang Ning, Mahmoud Ghandi, et al.
Nature Communications|December 21, 2017
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancerDavid Liu, Philip Abbosh, Daniel Keliher, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
Pageof 55

Showing results (431-440 of 549) with videos related to

Sort By:
Pageof 55
JAMA Oncology|July 17, 2015
Fusobacterium nucleatum and T Cells in Colorectal CarcinomaKosuke Mima, Yasutaka Sukawa, Reiko Nishihara, et al.
Nature Medicine|October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerA Vaishnavi, M Capelletti, A T Le, et al.
Genome Research|February 25, 2010
Integrative analysis of the melanoma transcriptomeMichael F Berger, Joshua Z Levin, Krishna Vijayendran, et al.
European Urology Oncology|June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed TherapyJesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Gut|August 28, 2015
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosisKosuke Mima, Reiko Nishihara, Zhi Rong Qian, et al.
Nature Medicine|May 10, 2019
The landscape of cancer cell line metabolismHaoxin Li, Shaoyang Ning, Mahmoud Ghandi, et al.
Nature Communications|December 21, 2017
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancerDavid Liu, Philip Abbosh, Daniel Keliher, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
Pageof 55